4//SEC Filing
Kiley Alison 4
Accession 0001209191-11-043226
CIK 0001338042other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:40 PM ET
Size
8.5 KB
Accession
0001209191-11-043226
Insider Transaction Report
Form 4
Kiley Alison
Director10% Owner
Transactions
- Purchase
Common Stock
2011-08-09$12.45/sh+5,500$68,497→ 2,690,251 total(indirect: See Footnotes) - Purchase
Common Stock
2011-08-08$12.43/sh+4,200$52,204→ 2,684,751 total(indirect: See Footnotes)
Holdings
- 2,680,551(indirect: See Footnotes)
Common Stock
Footnotes (3)
- [F1]The reporting person is a member of Alta BioPharma Management III, LLC ("ABMIII"), which is the general partner of Alta BioPharma Partners III, L.P. ("ABPIII") and the managing limited partners of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). She may be deemed to share investment power over the securities of the Issuer held by ABPIII, ABPIIIKG, and Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII") with the directors of ABMIII and managers of AEBPIII but disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein.
- [F2]On August 8, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 3847, 258, and 95 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.4296 per share.
- [F3]On August 9, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 5038, 338, and 124 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.454 per share.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeother
Related Parties
1- filerCIK 0001341637
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 5:40 PM ET
- Size
- 8.5 KB